IL139964A - Reference compound for use in the analysis of levosimendan batches - Google Patents

Reference compound for use in the analysis of levosimendan batches

Info

Publication number
IL139964A
IL139964A IL13996499A IL13996499A IL139964A IL 139964 A IL139964 A IL 139964A IL 13996499 A IL13996499 A IL 13996499A IL 13996499 A IL13996499 A IL 13996499A IL 139964 A IL139964 A IL 139964A
Authority
IL
Israel
Prior art keywords
analysis
reference compound
levosimendan
batches
levosimendan batches
Prior art date
Application number
IL13996499A
Other languages
English (en)
Other versions
IL139964A0 (en
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of IL139964A0 publication Critical patent/IL139964A0/xx
Publication of IL139964A publication Critical patent/IL139964A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N2030/042—Standards
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL13996499A 1998-06-18 1999-06-18 Reference compound for use in the analysis of levosimendan batches IL139964A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981428A FI104718B (fi) 1998-06-18 1998-06-18 [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä
PCT/FI1999/000539 WO1999065888A2 (en) 1998-06-18 1999-06-18 A reference compound for use in the analysis of levosimendan batches

Publications (2)

Publication Number Publication Date
IL139964A0 IL139964A0 (en) 2002-02-10
IL139964A true IL139964A (en) 2003-07-06

Family

ID=8552039

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13996499A IL139964A (en) 1998-06-18 1999-06-18 Reference compound for use in the analysis of levosimendan batches

Country Status (28)

Country Link
US (1) US6340764B1 (es)
EP (1) EP1087956B1 (es)
JP (1) JP4550279B2 (es)
KR (1) KR100661772B1 (es)
CN (1) CN1129590C (es)
AR (1) AR018879A1 (es)
AT (1) ATE253566T1 (es)
AU (1) AU755699B2 (es)
BR (1) BR9911230A (es)
CA (1) CA2334864C (es)
CZ (1) CZ298659B6 (es)
DE (1) DE69912604D1 (es)
EA (1) EA002854B1 (es)
ES (1) ES2211113T3 (es)
FI (1) FI104718B (es)
HK (1) HK1032779A1 (es)
HR (1) HRP20000866B1 (es)
HU (1) HU229582B1 (es)
ID (1) ID29239A (es)
IL (1) IL139964A (es)
MX (1) MXPA00012436A (es)
NO (1) NO325393B1 (es)
NZ (1) NZ508557A (es)
PL (1) PL201772B1 (es)
RS (1) RS49929B (es)
SK (1) SK284353B6 (es)
WO (1) WO1999065888A2 (es)
ZA (1) ZA200006993B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005015174D1 (de) 2004-04-21 2009-08-13 Teva Pharma Verfahren zur herstellung von montelukast-natrium
FR2877013A1 (fr) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
CA2608369A1 (en) 2005-07-05 2007-01-11 Teva Pharmaceutical Industries Ltd. Purification of montelukast
CN104230816B (zh) * 2014-09-19 2017-02-15 成都新恒创药业有限公司 一种左西孟旦潜在基因毒性杂质及其制备、检测方法
CN104478809B (zh) * 2014-11-14 2016-08-17 成都新恒创药业有限公司 一种左西孟旦杂质及其制备和检测方法
CN105817632A (zh) * 2015-01-09 2016-08-03 中国科学院宁波材料技术与工程研究所 片状粉末的制备装置及方法
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB383449A (en) * 1931-12-12 1932-11-17 Percy Charles Barton Improvements relating to masts, poles, or like supports and their manufacture
GB565546A (en) * 1943-04-13 1944-11-15 Leslie Frederick Reeve A pneumatically operated pickup unit for use in electric organs and the like
FI894035A (fi) * 1988-09-07 1990-03-08 Orion Yhtymae Oy Foerfarande foer framstaellning av nya substituerade pyridazinoner.
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
GB9915179D0 (en) * 1999-06-29 1999-09-01 Orion Corp A method for the treatment or prevention of coronary graft vasospasm

Also Published As

Publication number Publication date
PL201772B1 (pl) 2009-05-29
ATE253566T1 (de) 2003-11-15
YU76700A (sh) 2002-11-15
NO20006444D0 (no) 2000-12-15
KR100661772B1 (ko) 2006-12-28
CZ20004555A3 (en) 2001-05-16
CN1306527A (zh) 2001-08-01
HU229582B1 (en) 2014-02-28
NZ508557A (en) 2002-05-31
CA2334864A1 (en) 1999-12-23
SK284353B6 (sk) 2005-02-04
CZ298659B6 (cs) 2007-12-12
HK1032779A1 (en) 2001-08-03
HUP0102020A3 (en) 2002-04-29
EA002854B1 (ru) 2002-10-31
IL139964A0 (en) 2002-02-10
NO325393B1 (no) 2008-04-21
WO1999065888A3 (en) 2000-01-27
HUP0102020A2 (hu) 2001-12-28
MXPA00012436A (es) 2002-06-04
FI981428A (fi) 1999-12-19
AU755699B2 (en) 2002-12-19
DE69912604D1 (de) 2003-12-11
WO1999065888A2 (en) 1999-12-23
ZA200006993B (en) 2002-02-28
HRP20000866A2 (en) 2001-12-31
RS49929B (sr) 2008-09-29
CN1129590C (zh) 2003-12-03
HRP20000866B1 (en) 2009-02-28
FI104718B (fi) 2000-03-31
JP4550279B2 (ja) 2010-09-22
AR018879A1 (es) 2001-12-12
ID29239A (id) 2001-08-16
CA2334864C (en) 2008-01-15
KR20010072622A (ko) 2001-07-31
EA200100055A1 (ru) 2001-06-25
PL347577A1 (en) 2002-04-08
NO20006444L (no) 2000-12-15
AU4786399A (en) 2000-01-05
US6340764B1 (en) 2002-01-22
EP1087956B1 (en) 2003-11-05
EP1087956A2 (en) 2001-04-04
ES2211113T3 (es) 2004-07-01
BR9911230A (pt) 2001-03-06
FI981428A0 (fi) 1998-06-18
JP2002518383A (ja) 2002-06-25
SK18722000A3 (sk) 2001-09-11

Similar Documents

Publication Publication Date Title
EP1102535A4 (en) COMPOUNDS AND METHODS
EP1073817A4 (en) sliding bolt
GB9818914D0 (en) Use
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
DE69908946D1 (en) Phenyl-methoxyimino-essigsäurederivate als pestizide
GB2342863B (en) Probe
IL139964A (en) Reference compound for use in the analysis of levosimendan batches
ZA200006206B (en) Benzazole compounds and their use.
GB9905318D0 (en) Powder analysis
GB9803425D0 (en) Microtome
EP1113780A4 (en) METHOD FOR DETERMINING THE ACTIVITY OF COMPLEX NICHES
GB9707743D0 (en) Analysis
AU137894S (en) Slide latch
DE59909049D1 (en) Substituierte thiadiazolsulfonamide als interleukin-1-beta-hemmer
AU135006S (en) Slide latch
DE69908774D1 (en) Phenyl-methoxyimino-glyoxylsäureester-derivate als pestizide
GB9828076D0 (en) Detector
GB2338062B (en) Heteroduplex analysis
GB9807503D0 (en) Use
GB2332909B (en) Glycerol-based fluidifing substance
GB0022726D0 (en) Not available at present
GB9804780D0 (en) Microtome
GB9824451D0 (en) Detector
GB9824452D0 (en) Detector
GB9824453D0 (en) Detector

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired